Although this manuscript has analyzed the status of EGFR gene mutations and EGFR/TTF-1 protein expression levels on 1506 cases of NSCLC patients, the lack of prognoses data and biochemical mechanism research limited the scope of this study. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.